ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
1.132 |
Evidence |
|
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
1.132 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
MMP13 |
MMP13: Collagenase 3 precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.132 |
Evidence |
|
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
1.132 |
Evidence |
|
TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
1.132 |
Evidence |
|
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
CASP8 |
CASP8, MCH5: Caspase-8 precursor |
1.132 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
1.132 |
Evidence |
|
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
THOC1 |
THOC1, HPR1: THO complex subunit 1 |
1.132 |
Evidence |
|
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINB4 |
SERPINB3, SCCA, SCCA1: Serpin B3 |
1.132 |
Evidence |
|
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.132 |
Evidence |
|
F11 |
F11: Coagulation factor XI precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
1.132 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
1.132 |
Evidence |
|
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
1.132 |
Evidence |
|
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
1.132 |
Evidence |
|
TRPV6 |
TRPV6, ECAC2: Transient receptor potential cation channel subfamily V member 6 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.132 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
1.132 |
Evidence |
|
F8 |
F8, F8C: Coagulation factor VIII precursor |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
1.132 |
Evidence |
|
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
DRD2 |
DRD2: D(2) dopamine receptor |
1.132 |
Evidence |
|